Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Eikon Therapeutics, Inc.Listing unverified | Buy | $1M | conv 45First in 12mo | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $438.4K | conv 65ClusterUnusual size | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $12.8M | conv 66ClusterUnusual size | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $9K | conv 41ClusterFirst in 12mo | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $35.3K | conv 33Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $263.5K | conv 41ClusterFirst in 12mo | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $1.2K | conv 33Cluster | SEC |